Abstract:BACKGROUND: Endothelial dysfunction, a hallmark of diabetes, is a critical and initiating contributor to the pathogenesis of diabetic cardiovascular complications. However, the underlying mechanisms are still not fully understood. Ferroptosis is a newly defined regulated cell death driven by cellular metabolism and iron-dependent lipid peroxidation. Although the involvement of ferroptosis in disease pathogenesis has been shown in cancers and degenerative diseases, the participation of ferroptosis in the pathogenesis of diabetic endothelial dysfunction remains unclear.AIM: To examine the role of ferroptosis in diabetes-induced endothelial dysfunction and the underlying mechanisms.METHODS: Human umbilical vein endothelial cells (HUVECs) were treated with high glucose (HG), interleukin-1β (IL-1β), and ferroptosis inhibitor, and then the cell viability, reactive oxygen species (ROS), and ferroptosis-related marker protein were tested. To further determine whether the p53-xCT (the substrate-specific subunit of system Xc<sup>-</sup>)-glutathione (GSH) axis is involved in HG and IL-1β induced ferroptosis, HUVECs were transiently transfected with p53 small interfering ribonucleic acid or NC small interfering ribonucleic acid and then treated with HG and IL-1β. Cell viability, ROS, and ferroptosis-related marker protein were then assessed. In addition, we detected the xCT and p53 expression in the aorta of db/db mice.RESULTS: It was found that HG and IL-1β induced ferroptosis in HUVECs, as evidenced by the protective effect of the ferroptosis inhibitors, Deferoxamine and ferrostatin-1, resulting in increased lipid ROS and decreased cell viability. Mechanistically, activation of the p53-xCT-GSH axis induced by HG and IL-1β enhanced ferroptosis in HUVECs. In addition, a decrease in xCT and the presence of de-endothelialized areas were observed in the aortic endothelium of db/db mice.CONCLUSION: Ferroptosis is involved in endothelial dysfunction and p53-xCT-GSH axis activation plays a crucial role in endothelial cell ferroptosis and endothelial dysfunction.

Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus

Molecular mechanism of ferroptosis and its role in the occurrence and treatment of diabetes

Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities

Ferroptosis: Mechanisms and role in diabetes mellitus and its complications

Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications

Ferroptosis as a potential new therapeutic target for diabetes and its complications

Role of ferroptosis in the process of diabetes-induced endothelial dysfunction

Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications

Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy

Ferroptosis and ferritinophagy in diabetes complications

Ferroptosis: Potential Targets and Emerging Roles in Pancreatic Diseases

Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy

Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Ferroptosis in life: To be or not to be

Vitamin D May Play a Vital Role in Alleviating Type 2 Diabetes Mellitus by Modulating the Ferroptosis Signaling Pathway

Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes

The mechanism of ferroptosis and its related diseases

Ferroptosis and metabolic syndrome and complications: association, mechanism, and translational applications

Roles of ferroptosis in type 1 diabetes induced spermatogenic dysfunction